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Abstract Chromosome translocations are especially
frequent in human lymphomas and leukemias but are
insufficient to drive carcinogenesis. Indeed, several of
the so-called tumor specific translocations have been
detected in peripheral blood of healthy individuals, find-
ing a higher frequency of some of them with aging. The
inappropriate repair of DNA double strand breaks by the
nonhomologous end joining (NHEJ) pathway is one of
the reasons for a translocation to occur. Moreover, fidel-
ity of this pathway has been shown to decline with age.
Although the mechanism underlying this inefficacy is
unknown, other repair pathways are inactivated by
methylation with aging. In this study, we analyzed the
implication of NHEJ genes methylation in the increase
of translocations with the age. To this aim, we deter-
mined the relationship between translocations and aging
in 565 Spanish healthy individuals and correlated these
data with the methylation status of 11 NHEJ genes. We
found higher frequency of BCL2-JH and BCR-ABL
(major) translocations with aging. In addition, we de-
tected that two NHEJ genes (LIG4 and XRCC6) pre-
sented age-dependent promoter methylation changes.
However, we did not observe a correlation between the
increase of translocations and methylation, indicating
that other molecular mechanisms are involved in the
loss of NHEJ fidelity with aging.
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Introduction
Chromosomal translocations are characteristic hallmarks
of many cancers, especially lymphoma and leukemia
(Nambiar and Raghavan 2013), resulting in the
deregulated expression of oncogenes or the generation
of novel fusion genes. However, despite being necessary,
translocations are insufficient to drive carcinogenesis
and additional genetic changes are required to achieve
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full transformation (Janz et al. 2003). Indeed, several
translocations have been observed in lymphocytes from
healthy individuals, including BCL2-JH, BCR-ABL,
NPM-ALK, BCL1-JH, or those involving BCL6 and
MLL genes (Biernaux et al. 1995; Bose et al. 1998;
Brassesco et al. 2009; Bäsecke et al. 2002; Janz et al.
2003; Maes et al. 2001; Rabkin et al. 2008; Schüler et al.
2003). Notably, diverse studies have shown that the
frequency of these translocations increase with aging
(Dölken et al. 2008; Schüler et al. 2003). Although the
mere presence of these translocations is not sufficient to
trigger cancer development, a recent study has related the
presence of BCL2-IGH translocation in blood from
healthy individuals with the higher risk of developing
follicular lymphoma (FL) (Roulland et al. 2014).
For a translocation to occur, one of the criteria that
needs to be fulfilled is the inappropriate repair of DNA
double strand breaks (DSBs) (Mani and Chinnaiyan
2010). In mammalian cells, this repair is preferentially
performed by the nonhomologous end joining (NHEJ)
pathway (Lieber 2010). Diverse studies have suggested
that fidelity of NHEJ repair declines with aging
(Gorbunova and Seluanov 2005; Karanjawala and
Lieber 2004; Seluanov et al. 2004), which may lead to
the increased genomic instability in the elderly. Although
themolecularmechanism underlying this inefficacy of the
NHEJ pathway with aging is still unknown, it has been
demonstrated that other repair pathways are inactivated
by the methylation of their genes (Thompson et al. 2010).
Specifically, several DNA repair and protection genes,
such as hMLH1, MGMT, or GSTP1, have been shown
to be methylated with aging (Christensen et al. 2009;
Fraga and Esteller 2007). Therefore, it can be expected
that NHEJ genes may also gain methylation with aging
and this could lead to an increase in translocations.
To check this hypothesis, we determined the relation-
ship between four tumor-specific chromosome translo-
cations present in healthy individuals (BCL2-JH, BCR-
ABL, MLL-AF4, and TEL-AML1) and aging. Next, we
correlated the presence of these translocations with the
methylation status of 11 NHEJ genes.
Material and methods
Study population
A total of 565 Spanish healthy individuals were includ-
ed in the study (Table 1). Blood samples were collected
at the Araba University Hospital, University of the
Basque Country, University Hospital Cruces and
General Valencia Hospital from 2004 to 2007 and are
deposited in the C.001171 collection of the Carlos III
Health Institute. Information about age and sex were
recorded for each individual. The study was approved
by the Ethical Committees of all institutions. Informed
consent was obtained from all patients, or from their
parents, before sample collection, following the Spanish
Organic Law 15/1999. Genomic DNA and RNA were
extracted from peripheral blood using conventional
procedures.
Detection of the BCL2-JH translocation
BCL2-JH translocation involving the major breakpoint
region (MBR) of the BCL2 genewas analyzed in 1μg of
DNA, using a nested polymerase chain reaction (n-
PCR). Twenty samples were eliminated because there
was not enough material for the analysis (<1 μg DNA).
Of the total of 565 individuals, 545 were finally evalu-
ated. Primers sequences and PCR conditions are de-
scribed in Supplemental Table 1. The sensitivity to
detect the translocation, determined by a serial dilution
of the Karpas 422 cell line, was one in 106 normal cells.
Detection of the BCR-ABL, MLL-AF4, and TEL-AML1
translocations
To investigate the occurrence of the translocations BCR-
ABL (involving major and minor regions), MLL-AF4,
and TEL-AML1, a total of 500 ng of cDNA from 171
individuals with available RNAwas analyzed in a single
Table 1 Characteristics of the study population
Total number of participants 565
Age (mean, SD) 37.21±18.18
Age range (years) 1–84
Gender Number Percent
Male 321 56.8
Female 244 43.2
Study populations Number Age range
BCL2-JH 545 1–84
BCR-ABL, MLL-AF4,
TEL-AML1
171 1–84
NHEJ pathway
methylation
182 <20 years old
(n=91)
>40 years old
(n=91)
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assay by a multiplex n-PCR using a commercial kit
(Qiagen, Hilden, Germany). The first round was per-
formed with external primers, and the second one with
reverse internal primers marked with fluorescent dye at
their 5′-end following a previously published protocol
(Marín et al. 2001). The sequences of primers used in
both rounds of amplifications are described in
Supplemental Table 2. The cell lines SD1, Mv4-11,
and REH, harboring the BCR-ABL, MLL-AF4, and
TEL-AML1 translocations, respectively, were used as
positive controls. In addition, negative controls were
included in all reactions. All amplified products were
subsequently characterized by Genescan analysis in the
ABI 3100 genetic analyzer at SGIker. Samples
displaying a pick at the expected size by capillary elec-
trophoresis were considered positive.
Methylation-specific PCR
From the total of 565 individuals, 91≥40 and 91≤
20 years old were selected for methylation analyses
(Table 1). RAG1, RAG2, ATM, ATR, XRCC4, XRCC5,
NHEJ1, DCLRE1C, PRKDC, XRCC6, and LIG4 genes,
all belonging to the NHEJ DNA repair pathway, were
selected for methylation-specific PCR (MSP). We used
the UCSC Genome browser (genome.ucsc.edu/) to
identify CpG islands within these genes, and their meth-
ylation was analyzed by MSP. Briefly, genomic DNA
was converted by sodium bisulfite treatment using the
CpGenomeTM Fast DNAModification Kit (Chemicon®
Int), according to the manufacturer’s instructions. The
quality of the converted DNA was verified with the
amplification of the ACTB gene. Primer sequences and
PCR conditions are described in Supplemental Table 3.
DNA amplified with illustra GenomiPhi V2 kit (GE
Healthcare) was used as the negative control and
CpGenome universal methylated human DNA
(Millipore, Schwalbach, Germany) was the positive
control. Water blanks and genomic DNAs were includ-
ed with each assay.
Statistical analyses
The frequency of each translocation was defined as the
proportion of individuals positive for the translocation
with respect to the total population. A linear regression
model was used to analyze the relationship between the
age and frequency of translocations. The differences
between groups were analyzed by the chi-square test
using the STATA 8.0 software.
Promoter methylation was given as the percentage of
the methylated-positive individuals. Statistical differ-
ences between groups were examined with the chi-
square test using PASW Statistics software version 18
(SPSS Inc., Chicago, IL). Statistical significance was set
at P<0.05.
Results
Frequency of the Bcl2-JH translocation
The t(14;18)-MBR translocation was found in 206
(37.8 %) of the 545 individuals evaluated. We studied
the effect of aging, stratifying the population in eight
consecutive groups. Analysis of data showed a gradual
increase from 21.4% in the group of children (1–9 years
old) to 60 % among people older than 70 years
(Table 2). Comparison of the translocation frequencies
in each group with that found in the youngest group
demonstrated that the frequency of the t(14;18) started
to be significantly different at the age of 40. To verify
this tendency, we divided our population in individuals
younger (n=298), and older (n=247) than 40 years and
compared the frequency of translocation in these two
groups. We observed a significant higher frequency in
adults (46.2 %, 114/247) than in the group of young
people (30.9 %, 92/298) (P=0.0002) (Fig. 1).
Frequency of the BCR-ABL,MLL-AF4, and TEL-AML1
translocations
Out of the 171 healthy individuals analyzed, the trans-
location BCR-ABL major was found in 17 (9.9 %), the
BCR-ABL minor in 2 (1.2 %), and the MLL-AF4 in 11
individuals (6.4 %). TEL-AML1 rearrangement was not
detected in any individual.
The frequency of the BCR-ABL major andMLL-AF4
translocations were found to be related to aging: the
frequency of BCR-ABL major translocation increased
significantly with the age of the individuals from
4.8 % (4/83) in the group of people younger than
40 years old to 14.7 % (13/88) among older individuals
(P=0.004). In contrast, MLL-AF4 translocation was
more rare among individuals older than 40 years old
(1/88; 1 %) than in the group under this age (10/83;
12 %) (P=0.004) (Fig. 1).
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Methylation status of NHEJ genes
To determine the existence of association between the
presence of translocations and the inefficacy of the
NHEJ pathway because of epigenetic mechanisms, we
analyzed the methylation status of 11 genes encoding
proteins involved in the NHEJ pathway.
Our in silico analysis showed that the RAG1 and
RAG2 genes do not contain CpG islands, and therefore
were excluded from the study. Among the remaining
genes, seven (ATM, ATR, XRCC4, XRCC5, NHEJ1,
DCLRE1C, and PRKDC) displayed one CpG island
each and the other two genes (XRCC6 and LIG4) pre-
sented two each. In total, 11 CpG regions in the pro-
moter of nine genes were analyzed in 182 healthy indi-
viduals (91≥40 and 91≤20 years old).
We found that the frequency of samples showing
methylation was in general low (<5 %), except for the
XRCC5 gene promoter which was methylated in 50 %
of the samples (Table 3). ATR, XRCC6 region 1, and
LIG4 region 1 showed methylation in 4, 5, and 3 % of
the samples, respectively. XRCC4, DCLRE1C, NHEJ1,
ATM, and LIG4 region 2 showed methylation percent-
ages ranging from 0.5 to 2 %. PRKDC and XRCC6
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Fig. 1 Prevalence of translocation positivity according to the age
of individuals. For BCL-JH, a total of 545 individuals were ana-
lyzed (298<40 vs 247>40 years old). For the BCR-ABL, MLL-
AF4 and TEL-AML1 chromosome translocations, 171 individuals
were studied (83<40 vs 88>40 years old). Asterisk represents
statistically significant results
Table 2 Prevalence of t(14;18) by age groups
Range age (years) Number t(14;18), number (%) OR P value Confidence interval (95 %)
1–9 42 9 (21.4) 1.00 – –
10–19 79 28 (35.4) 2.01 0.115 0.84–4.80
20–29 78 18 (23.1) 1.10 0.837 0.44–2.72
30–39 99 37 (34.4) 2.18 0.068 0.94–5.07
40–49 107 48 (44.9) 2.98 0.010 1.30–6.83
50–59 81 34 (42.0) 2.65 0.026 1.12–6.26
60–69 39 20 (51.2) 4.34 0.001 1.77–10.66
>70 20 12 (60.0) 4.62 0.001 1.84–12.55
OR odds ratio
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region 2 showed nomethylation. Remarkably, 12.1% of
all individuals showed methylation in more than one
CpG island.
Considering the age of individuals, individuals
>40 years old showed in general a higher methylation
frequency (at least one CpG island methylated) in com-
parison with people younger than 20 years (68.1 vs
50.5 %) (P=0.02). Specifically, we observed a signifi-
cant increase in LIG4 methylation with the age (0 vs
8.8 %; P=0.02). XRCC5 methylation also showed an
increase with the age (42.8 vs 57.1 %), although it did
not reach the statistically significant value (P=0.05). In
contrast, the frequency of XRCC6 methylation was
higher in individuals <20 years compared with older
individuals (>40 years old) (9.9 vs 1.1 %; P=0.01).
The rest of CpG islands analyzed showed no remarkable
results (Fig. 2). Finally, when the presence of more than
one CpG island methylated was studied, no differences
between adults and young people were found (11 vs
13.2 %; P=0.06).
Among individuals with a translocation, the frequen-
cy of individuals >40 years old with at least one meth-
ylated CpG island was slightly higher than that obtained
for the group of individuals younger than <20 years old
(56.6 vs 50 %; P=0.6). Surprisingly, among individuals
without translocations, the frequency of methylation
was significantly higher among individuals older than
40 years old (80.4 vs 50.9 %; P=0.002) (Table 4). No
differences in the frequency of methylation between
samples with and without translocations were detected
(53.2 vs 64.1 %; P=0.14).
Discussion
The present study shows that methylation of NHEJ
pathway genes does not contribute significantly to the
increase of translocations with the age. Although we
observed a higher frequency of Bcl2-JH and BCR-ABL
(major) translocations with aging and two NHEJ genes
presented age-dependent promoter methylation chang-
es, we did not observe a correlation between these two
events.
Both translocations, BCL2-JH and BCR-ABL, are
chromosome abnormalities characteristics of adult lym-
phomas. The BCL2-JH or t(14;18) translocation is a
genetic hallmark of FL. In our study population, we
detected that this rearrangement was present in 37.8 %
of our population, similar to that described in other
studies performed in healthy individuals (40–60 %)
(Nambiar and Raghavan 2012). Moreover, the frequen-
cy of the translocation increased with the age of indi-
viduals (30.9 vs 46.2 %), results which were also in line
with previous studies (Dölken et al. 2008; Liu et al.
1994; Nambiar and Raghavan 2010; Schüler et al.
2009). The chromosome translocation BCR-ABL or
t(9;22) involving the major region of BCR is found in
patients with chronic myeloid leukemia (CML) and
adult acute lymphoblastic leukemia (Zhen and Wang
2013). This translocation was also detected in blood
cells of 9.9 % healthy individuals of our study popula-
tion. This frequency was lower than those previously
reported (∼20%) by other authors (Biernaux et al. 1995;
Bose et al. 1998). In addition, a significant increase of
the frequency of the BCR-ABL translocation was de-
tected with the age of individuals (4.8 % in <40 years
old vs 14.7 % in >40 years old). In contrast, MLL-AF4
or t(4;11) translocation, characteristic of pediatric acute
lymphoblastic leukemia and uncommon in adult leuke-
mia, was found to be more frequent in individuals
younger than 40 years old than in adults (12 vs 1 %).
These results can be explained by the mechanisms in-
volved in the biogenesis of translocations, which in-
clude the spatial proximity of chromosomes (Parada
and Misteli 2002). The proximity between BCL2-JH
and BCR-ABL has been already demonstrated in lym-
phocytes of adults (Neves et al. 1999; Roix et al. 2003).
Hence, the higher frequency of these translocations in
Table 3 Methylation status of nine NHEJ genes in 182 healthy
individuals
MSP + MSP −
CpG island Number (%) Number (%)
ATR 8 (4) 174 (96)
XRCC4 1 (0.5) 181 (99.5)
XRCC5 91 (50) 91 (50)
XRCC6 CpG1 10 (5) 172 (95)
XRCC6 CpG2 0 (0) 182 (100)
DCLRE1C 1 (0.5) 181 (99.5)
NHEJ1 5 (3) 177 (97)
LIG4 CpG1 5 (3) 177 (97)
LIG4 CpG 2 3 (1.6) 179 (98.4)
ATM 2 (1) 180 (99)
PRKDC 0 (0) 182 (100)
MSP methylation-specific PCR, + positive, − negative
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adults could be due to the acquisition of de novo alter-
ations with the age because of replication errors.
However, MLL-AF4 translocation occurs more fre-
quently in children. The origin of pediatric cancers has
been suggested to happen during the embryonic devel-
opment (Brassesco 2008; Greaves 2003), so an expla-
nation for the decrease of this rearrangement with the
age could be that these loci are close during embryo-
genesis, but this proximity disappears in adults.
Nowadays, the biological significance of the occur-
rence of translocations in healthy people still remains
unresolved, although a recent study has showed that the
presence of BCL2-IgH translocation in blood from
healthy individuals works as a predictive biomarker
for FL, being effective years before diagnosis
(Roulland et al. 2014). This means that the determina-
tion of translocations in healthy individuals could be a
useful tool to predict the risk of developing some lym-
phomas or leukemias in the near future.
To determine if the increase of BCL2-JH and BCR-
ABL translocations with aging was the result of NHEJ
pathway genes silencing through epigenetic mecha-
nisms, we analyzed the methylation status of 11 NHEJ
genes considering the frequency of translocations and
the age. We found a higher number of individuals with
the LIG4 promoter methylated in the group of adults
(>40 years old) compared with the younger group
(≤20 years old) (8.8 vs 0 %). Remarkably, LIG4 promot-
er was also found to be hypermethylated in different
types of lymphomas (Martín-Subero et al. 2009).
However, no analysis on healthy individuals had been
done until now. LIG4 forms together with XRCC4 a
complex that is responsible for the NHEJ final ligation
step (Ahnesorg et al. 2006; Buck et al. 2006). The
fundamental role of these two factors has been thorough-
ly demonstrated. Mutations in LIG4 lead to variable
immunodeficiency, developmental delay, chromosome
alterations, and microcephaly (Buck et al. 2006;
O’Driscoll et al. 2001). Of note is the fact that LIG4 or
XRCC4 deficient mouse B cells showed decreased class-
switch recombination and substantial levels of IgH locus
chromosomal breaks (Yan et al. 2007). Therefore, we
could speculate that LIG4 promoter hypermethylation,
observed in a higher frequency in adults, could lead to
LIG4 gene silencing in some cells, increasing the risk of
translocations in this group. However, no significant
results were observedwhen the frequency ofmethylation
and translocation were analyzed together.
Table 4 Methylation status of 182 healthy individuals in relation
to age and the presence of translocations
Age Yes, number, (%) No, number, (%) P valuea
Translocation Methylation
>40 years 25 (56.6) 20 (44.4) 0.6
≤20 years 17 (50.0) 17 (50.0)
No translocation Methylation
>40 years 37 (80.4) 9 (19.6) 0.002
≤20 years 29 (50.9) 28 (49.1)
aX2 test was applied
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Fig. 2 Methylation-specific PCR results. The percentage of methylation in 9 CpG islands was compared in young people ≤20 years old vs
adults >40 years old. Asterisk represents statistically significant results
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The XRCC5 gene promoter was also found to be
methylated in a higher number of healthy adults (57.1
vs 42.8 %, although not statistically significant). The
deregulation of XRCC5 due to the hypermethylation of
its promoter was also observed in a subset of non-small
cell lung cancer patients (Lee and McKinnon 2007). By
contrast, the methylation of XRCC6 promoter was sig-
nificantly less frequent in the older group (1.1 vs 9.9 %).
XRCC5 and XRCC6 encode for the ku80 and ku70
proteins, respectively, which form the Ku heterodimer.
Alterations of this complex have been related to the
decreased DNA repair capacity in the elderly (Doria
et al. 2004; Ju et al. 2006; Seluanov et al. 2007).
However, according to our results, the methylation
changes observed in these two genes during aging
seems to be not associated with an increase of translo-
cations frequency.
In summary, in the present work, we show a higher
frequency of two translocations with the age that cannot
be explained by a loss of fidelity of NHEJ pathway with
aging through the methylation of its genes. This sug-
gests the involvement of other unknown molecular
mechanisms.
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